Major histocompatibility complex restriction and transplantation immunity. A possible solution to the allograft problem.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMID 6364484)

Published in Transplantation on January 01, 1984

Authors

W K Silvers, S T Bartlett, H D Chen, H L Fleming, A Naji, C F Barker

Articles by these authors

Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol (2001) 12.00

Randomised trial of hysterectomy, endometrial laser ablation, and transcervical endometrial resection for dysfunctional uterine bleeding. BMJ (1994) 5.76

Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med (2001) 4.07

Quantitative studies on the mixed lymphocyte interaction in rats. II. Relationship of the proliferative response to the immunologic status of the donors. J Exp Med (1967) 3.82

Genetics and immunology of sex-linked antigens. Adv Immunol (1972) 2.71

The role of afferent lymphatics in the rejection of skin homografts. J Exp Med (1968) 2.60

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant (2007) 2.50

Comparison of open and laparoscopic live donor nephrectomy. Ann Surg (1997) 2.43

The Effects of Genotype and Cell Environment on Melanoblast Differentiation in the House Mouse. Genetics (1956) 2.37

Immunologically privileged sites. Adv Immunol (1977) 2.35

Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J Vasc Surg (2001) 2.27

Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science (1990) 2.25

"Intrinsic" immunological tolerance in allophenic mice. Science (1967) 2.10

Mixed leukocyte reactions and histocompatibility in rats. Science (1967) 1.99

A comparison of recipient renal outcomes with laparoscopic versus open live donor nephrectomy. Transplantation (1999) 1.88

Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J Virol (2001) 1.87

Towne-vaccine-induced prevention of cytomegalovirus disease after renal transplants. Lancet (1984) 1.81

B-cells are required for the initiation of insulitis and sialitis in nonobese diabetic mice. Diabetes (1997) 1.75

A technique for management of multiple renal arteries after laparoscopic donor nephrectomy. Transplantation (1997) 1.67

Estimated benefits of transplantation of kidneys from donors at increased risk for HIV or hepatitis C infection. Am J Transplant (2007) 1.63

Distinctive clinical features of portopulmonary hypertension. Chest (1997) 1.59

I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice. J Immunol (1999) 1.56

Antigen presenting function of class II MHC expressing pancreatic beta cells. Nature (1988) 1.56

Popliteal artery aneurysms: current management and outcome. J Vasc Surg (1994) 1.55

Genes and the Pigment Cells of Mammals: Pigment cells provide unique material for studying the interactions of genetic determinants. Science (1961) 1.55

Genetic control of the immune response in mice. 3. An association between H-2 type and reaction to H-Y. J Immunol (1971) 1.52

The Maryland aggregate pathology index: a deceased donor kidney biopsy scoring system for predicting graft failure. Am J Transplant (2008) 1.48

Perivascular location and phenotypic heterogeneity of microglial cells in the rat brain. J Neuroimmunol (1990) 1.45

Magnetic resonance angiography of peripheral runoff vessels. J Vasc Surg (1992) 1.45

Late failure of reversed vein bypass grafts. Ann Surg (1989) 1.41

A twenty-two year review of elective resection of abdominal aortic aneurysms. Surg Gynecol Obstet (1976) 1.40

The use of bladder for total transplant ureteral reconstruction. J Urol (1998) 1.40

Increased rates of donation with laparoscopic donor nephrectomy. Ann Surg (2000) 1.40

Human polyoma virus in renal allograft biopsies: morphological findings and correlation with urine cytology. Hum Pathol (1999) 1.39

A high panel-reactive antibody rescue protocol for cross-match-positive live donor kidney transplants. Transplantation (2000) 1.39

Laparoscopic versus open donor nephrectomy: comparing ureteral complications in the recipients and improving the laparoscopic technique. Transplantation (1999) 1.38

Islet cell damage associated with tacrolimus and cyclosporine: morphological features in pancreas allograft biopsies and clinical correlation. Transplantation (1999) 1.35

High levels of glucose-6-phosphatase gene and protein expression reflect an adaptive response in proliferating liver and diabetes. J Clin Invest (1995) 1.33

Laparoscopic live donor nephrectomy: the University of Maryland 3-year experience. J Urol (2000) 1.32

Typing and immunosuppression in rats. Transplantation (1967) 1.31

Occurrence of donor Langerhans cells in mouse and rat chimeras and their replacement in skin grafts. J Invest Dermatol (1986) 1.29

Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol (2000) 1.29

Living-related donors with bilateral multiple renal arteries. A twenty-year experience. Transplantation (1989) 1.28

Morphological spectrum of polyoma virus disease in renal allografts: diagnostic accuracy of urine cytology. Am J Transplant (2001) 1.28

Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J Vasc Surg (2001) 1.27

Male-specific antigen: modification of potency by the H-2 locus in mice. Science (1973) 1.27

Genetic determinants of immunological responsiveness. Adv Immunol (1974) 1.26

The role of pretransplant immunity in protection from cytomegalovirus disease following renal transplantation. Transplantation (1985) 1.26

Histocompatibility antigens on melanoblasts and hair follicle cells. Cell-localized homograft rejection in allophenic skin grafts. Transplantation (1970) 1.24

Langerhans cells in mouse skin experimentally deprived of its neural crest component. J Invest Dermatol (1968) 1.23

The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL. J Immunol (1997) 1.22

Studies on the conservation of epidermal specificies of skin and certain mucosas in adult mammals. J Exp Med (1967) 1.21

Colonic necrosis following sodium polystyrene sulfonate (Kayexalate)-sorbitol enema in a renal transplant patient. Report of a case and review of the literature. Dis Colon Rectum (1993) 1.17

The role of regional lymphatics in the skin homograft response. Transplantation (1967) 1.17

The detrimental effect of poor early graft function after laparoscopic live donor nephrectomy on graft outcomes. Am J Transplant (2008) 1.17

Transplantation of isolated pancreatic islets across strong and weak histocompatibility barriers. Transplant Proc (1973) 1.16

Spontaneous diabetes in rats: destruction of islets is prevented by immunological tolerance. Science (1981) 1.16

Glutamine enhancement of structure and function in transplanted small intestine in the rat. JPEN J Parenter Enteral Nutr (1993) 1.15

Analytical and functional studies on the T cells of untreated and immunologically tolerant diabetes-prone BB rats. J Immunol (1983) 1.15

Further studies on the induction of tolerance of skin homografts in rats. J Exp Zool (1966) 1.14

Increased living donor volunteer rates with a formal recipient family education program. Am J Kidney Dis (1997) 1.13

Genetic background and expressivity of histocompatibility genes. Science (1967) 1.12

Algorithm for total face and multiorgan procurement from a brain-dead donor. Am J Transplant (2013) 1.11

Spontaneous diabetes in BB rats: evidence for a T cell dependent immune response defect. Diabetologia (1982) 1.10

An association between H-2 and the expressivity of H-Y in murine skin grafts. Transplant Proc (1973) 1.10

Treatment of portal vein thrombosis after liver transplantation with percutaneous thrombolysis and stent placement. J Vasc Interv Radiol (1994) 1.10

Prevention of autoimmune diabetes in the BB rat by intrathymic islet transplantation at birth. Science (1992) 1.10

A novel approach to the treatment of chronic allograft nephropathy. Transplantation (1997) 1.10

Importance of chimerism in maintaining tolerance of skin allografts in mice. J Immunol (1973) 1.09

Transgenic mouse model of malignant skin melanoma. Proc Natl Acad Sci U S A (1993) 1.09

Perigraft air, fever, and leukocytosis after endovascular repair of abdominal aortic aneurysms. Am J Surg (1999) 1.08

The genetic basis of male skin rejection in mice. Transplantation (1971) 1.07

The evolution of a successful liver transplant program in 1996: the clinical and administrative role of the anesthesiologist. Liver Transpl Surg (1997) 1.07

Isolated pancreas rejection in combined kidney pancreas tranplantation. Transplantation (1996) 1.07

Successful restoration of renal allograft function with urokinase thrombolysis in the setting of phlegmasia cerulea dolens. J Vasc Interv Radiol (1995) 1.07

Salvage of renal allograft function and lower extremity venous patency with thrombolytic therapy: case report and review of the literature. J Vasc Surg (1995) 1.06

Prevention of autoimmune recurrence and rejection by adenovirus-mediated CTLA4Ig gene transfer to the pancreatic graft in BB rat. Diabetes (1999) 1.05

Prevention of diabetes in rats by bone marrow transplantation. Ann Surg (1981) 1.05

Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transplant (2008) 1.05

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. Leukemia (2008) 1.04

Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation (1997) 1.04

Skeletal muscle as a privileged site for orthotopic skin allografts. J Exp Med (1973) 1.04

Physiological and immunological consequences of transplanting isolated pancreatic islets. Surgery (1973) 1.03

Impaired CD4 T cell activation due to reliance upon B cell-mediated costimulation in nonobese diabetic (NOD) mice. J Immunol (2000) 1.03

Percutaneous thrombolysis and stent placement for the treatment of portal vein thrombosis after liver transplantation: long-term follow-up. Transplantation (1998) 1.03